Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitor

• 收藏
• 分享

专利权人:

Merck Patent GmbH

发明人:

Bladt, Friedhelm,Friese-Hamim, Manja

申请号：

AU2015360005

公开号：

AU2015360005A1

申请日:

2015.11.12

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof in combination with N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxy-anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/